Dosing protocols
Peptide dosing protocols
A literature-first index of 12 compounds readers ask about most - recovery peptides like BPC-157 and TB-500, metabolic agents from MOTS-C through GLP-1 medicines, growth-hormone secretagogues, NAD+, and melanocortin peptides. Each row shows the route usually discussed, a representative dose range, and the use case people cite - not a prescription or a verified safe human dose.
Six entries link to full protocol pages with published ranges, reconstitution notes, side effects, and 2026 legal status. The rest are shorter index entries for compounds we have not expanded yet. Where you only need BAC-water dilution math - not a clinical protocol - use the peptide calculator.
For laboratory and documentary use only. Pepsider does not sell peptides or solvents; verify every vial label, COA, and institutional policy independently.
Compare routes, doses, and use cases
Route is how the compound is usually administered in labels or community protocols - here, overwhelmingly subcutaneous. Dose is a shorthand range from trials, approved labels, or commonly cited schedules; grey-market vials may not match what is on the label. Category is what readers typically use it for: tissue healing, weight loss, growth-hormone support, tanning, and similar goals.
Open a protocol for the full write-up - loading phases, stacking context, safety flags, and where calculator tools stop being useful.
| Peptide | Route | Dose | Category | Protocol |
|---|---|---|---|---|
| BPC-157 | Subcutaneous | ~200–500 mcg/day SC. | Tissue & gut healing | Read |
| TB-500 | Subcutaneous | ~2–2.5 mg, 2× weekly SC. | Tissue repair | Read |
| GHK-Cu | Subcutaneous | ~1–2 mg, 2–3× weekly SC. | Skin & collagen | Read |
| Retatrutide | Subcutaneous | ~2–12 mg/week SC. | Weight loss | Read |
| MOTS-c | Subcutaneous | ~5–10 mg/week SC. | Metabolism & exercise | Read |
| Semaglutide | Subcutaneous | ~0.25–2.4 mg/week SC. | Weight loss & diabetes | Read |
| Tirzepatide | Subcutaneous | ~2.5–15 mg/week SC. | Weight loss & diabetes | Read |
| Ipamorelin | Subcutaneous | ~100–300 mcg, 1–3× daily SC. | Growth hormone release | Read |
| CJC-1295 | Subcutaneous | ~100 mcg, 2–3× daily SC. | Growth hormone release | Read |
| PT-141 | Subcutaneous | ~1.75 mg, as needed SC. | Sexual health | Read |
| Melanotan II | Subcutaneous | ~100–500 mcg/day SC. | Tanning & libido | Read |
| NAD+ | Subcutaneous | ~50–100 mg, 2–3× weekly SC. | Cellular energy | Read |
BPC-157
Route
Subcutaneous
Dose
~200–500 mcg/day SC.
Category
Tissue & gut healing
Open protocolTB-500
Route
Subcutaneous
Dose
~2–2.5 mg, 2× weekly SC.
Category
Tissue repair
Open protocolGHK-Cu
Route
Subcutaneous
Dose
~1–2 mg, 2–3× weekly SC.
Category
Skin & collagen
Open protocolRetatrutide
Route
Subcutaneous
Dose
~2–12 mg/week SC.
Category
Weight loss
Open protocolMOTS-c
Route
Subcutaneous
Dose
~5–10 mg/week SC.
Category
Metabolism & exercise
Open protocolSemaglutide
Route
Subcutaneous
Dose
~0.25–2.4 mg/week SC.
Category
Weight loss & diabetes
Open protocolTirzepatide
Route
Subcutaneous
Dose
~2.5–15 mg/week SC.
Category
Weight loss & diabetes
Open protocolIpamorelin
Route
Subcutaneous
Dose
~100–300 mcg, 1–3× daily SC.
Category
Growth hormone release
Open protocolCJC-1295
Route
Subcutaneous
Dose
~100 mcg, 2–3× daily SC.
Category
Growth hormone release
Open protocolPT-141
Route
Subcutaneous
Dose
~1.75 mg, as needed SC.
Category
Sexual health
Open protocolMelanotan II
Route
Subcutaneous
Dose
~100–500 mcg/day SC.
Category
Tanning & libido
Open protocolNAD+
Route
Subcutaneous
Dose
~50–100 mg, 2–3× weekly SC.
Category
Cellular energy
Open protocol